In addition, a limited number of studies have investigated the possibility of using BNP and other biomarkers in the early detection of anthracycline-induced cardiotoxicity in children/long-term survivors of childhood cancer with the majority of studies supporting BNP as a useful biomarker of myocardial dysfunction [32]–[36]. The gene discussed is NPPB; the disease is childhood malignant neoplasm.